NACO (National AIDS Control Organisation) is India's nodal agency specifically dedicated to HIV/AIDS prevention and control. Its mandate is highly focused: formulating and implementing policies, programs, and strategies solely for HIV/AIDS. In contrast, the National Health Mission (NHM) is a broader initiative encompassing various health programs, including maternal and child health, communicable and non-communicable diseases, and strengthening health infrastructure across the country. While NHM might integrate some HIV/AIDS services, NACO holds the primary, specialized responsibility for the epidemic.

ART has been a game-changer. Medically, it transformed HIV from a rapidly fatal disease into a manageable chronic condition. It suppresses the viral load to undetectable levels, allowing the immune system to recover and preventing opportunistic infections. Socially, this means people with HIV can live longer, healthier lives, work, and raise families, significantly reducing the fear and stigma associated with the diagnosis. It also dramatically reduces the risk of HIV transmission, including from mother to child, making prevention efforts more effective and offering a pathway towards ending the epidemic.

This is a complex issue. Arguments *for* the current deferral policy by the government and NBTC (National Blood Transfusion Council) center on public health safety, citing the 'even 1% chance of infection shouldn't be there' for recipients, especially given the high volume of transfusions. They argue that while screening is done, a residual risk, however small, cannot be entirely eliminated, and certain groups are statistically at higher risk. Arguments *against* the policy, as raised by petitioners, highlight that it is discriminatory, unscientific, and violates Articles 14 (equality) and 15 (non-discrimination) of the Constitution, especially when all donated blood is already tested. They suggest that modern testing methods are highly reliable. Balancing these requires a nuanced approach: continuously reviewing scientific advancements in testing, exploring risk-based individual assessments instead of blanket deferrals, and investing in public awareness to reduce stigma, while ensuring robust safety protocols remain paramount.

HIV (Human Immunodeficiency Virus) is the virus itself that attacks the immune system. AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV infection. A person is diagnosed with AIDS when their immune system is severely compromised, typically indicated by their CD4 T-cell count dropping below a critical level (usually 200 cells/mm³) or when they develop certain opportunistic infections or cancers that a healthy immune system would normally fight off. So, HIV is the cause, and AIDS is the severe manifestation of the disease.

NACO (National AIDS Control Organisation) is India's nodal agency specifically dedicated to HIV/AIDS prevention and control. Its mandate is highly focused: formulating and implementing policies, programs, and strategies solely for HIV/AIDS. In contrast, the National Health Mission (NHM) is a broader initiative encompassing various health programs, including maternal and child health, communicable and non-communicable diseases, and strengthening health infrastructure across the country. While NHM might integrate some HIV/AIDS services, NACO holds the primary, specialized responsibility for the epidemic.

ART has been a game-changer. Medically, it transformed HIV from a rapidly fatal disease into a manageable chronic condition. It suppresses the viral load to undetectable levels, allowing the immune system to recover and preventing opportunistic infections. Socially, this means people with HIV can live longer, healthier lives, work, and raise families, significantly reducing the fear and stigma associated with the diagnosis. It also dramatically reduces the risk of HIV transmission, including from mother to child, making prevention efforts more effective and offering a pathway towards ending the epidemic.

This is a complex issue. Arguments *for* the current deferral policy by the government and NBTC (National Blood Transfusion Council) center on public health safety, citing the 'even 1% chance of infection shouldn't be there' for recipients, especially given the high volume of transfusions. They argue that while screening is done, a residual risk, however small, cannot be entirely eliminated, and certain groups are statistically at higher risk. Arguments *against* the policy, as raised by petitioners, highlight that it is discriminatory, unscientific, and violates Articles 14 (equality) and 15 (non-discrimination) of the Constitution, especially when all donated blood is already tested. They suggest that modern testing methods are highly reliable. Balancing these requires a nuanced approach: continuously reviewing scientific advancements in testing, exploring risk-based individual assessments instead of blanket deferrals, and investing in public awareness to reduce stigma, while ensuring robust safety protocols remain paramount.

HIV (Human Immunodeficiency Virus) is the virus itself that attacks the immune system. AIDS (Acquired Immunodeficiency Syndrome) is the most advanced stage of HIV infection. A person is diagnosed with AIDS when their immune system is severely compromised, typically indicated by their CD4 T-cell count dropping below a critical level (usually 200 cells/mm³) or when they develop certain opportunistic infections or cancers that a healthy immune system would normally fight off. So, HIV is the cause, and AIDS is the severe manifestation of the disease.